TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 159 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 3,037,042 | $236,950,000 | 8.05% |
| MPM BioImpact LLC | 269,186 | $21,002,000 | 3.45% |
| Logos Global Management LP | 400,000 | $31,208,000 | 2.62% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 121,541 | $9,481,000 | 2.50% |
| Orbimed Advisors | 2,361,327 | $184,231,000 | 1.86% |
| First Light Asset Management, LLC | 395,825 | $30,882,000 | 1.85% |
| SECTORAL ASSET MANAGEMENT INC | 211,650 | $16,513,000 | 1.34% |
| Nicholas Investment Partners, LP | 224,876 | $17,545,000 | 1.10% |
| DAFNA Capital Management LLC | 47,852 | $3,733,000 | 0.78% |
| Eventide Asset Management | 578,000 | $45,096,000 | 0.61% |